Growblox Sciences, Inc. (GBLX) Bolstering Staff as
Post# of 118
Posted On: 09/01/2015 5:17:48 PM
Growblox Sciences, Inc. (GBLX) Bolstering Staff as Subsidiary Prepares to Commence Cultivation Operations
Growblox Sciences, Inc. (OTCQB: GBLX) is rapidly approaching the impending commencement of cultivation operations through its majority-owned subsidiary, GB Sciences Nevada, LLC. As a result, the company has turned much of its attention in recent weeks toward transitioning from an engineering intensive development stage to the day-to-day operations related to the production and branding of its innovative products. Among these efforts, Growblox has made significant progress in beefing up its staff to meet the increased demands of production efforts while simultaneously promoting sustainable revenue growth.
In July, the company announced the hiring of John Poss as a consultant. Poss brings more than 15 years of consulting experience to the Growblox team, as well as the knowledge gained from operating as a CEO, COO, CFO and CTO of both public and private firms with sales of up to $450 million. In August, the company built upon this relationship by appointing Poss as its new chief financial officer. Following this announcement, Growblox will look to lean on its newest executive’s considerable industry expertise in order to promote a smooth and expeditious strategic transition.
“First joining us as a consultant, the performance of John Poss and his impact on our company, made the hiring of him as a full-time key executive an obvious choice,” Craig Ellins, chief executive officer of Growblox, stated in a news release. “This choice supports our transition from the engineering intensive development stage to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue.”
While it continues to increase the size of its staff, Growblox is currently progressing toward the completion of its new cultivation facility, which will provide a pristine and consistent environment for growing and processing medical cannabis that will also safeguard the company’s proprietary technology and equipment. As of its latest update, Growblox plans to complete construction of the facility before the end of 2015, strategically positioning it to initiate revenue-generating operations as early as next year. In preparation, GB Sciences Nevada has already applied for certification to dispense medical cannabis at two locations in Clark County, Nevada, and it is currently awaiting approval.
With the considerable progress of GB Sciences, as well as the company’s ongoing efforts to finalize the production and testing of its groundbreaking GrowBLOX Suites system in 2016, Growblox is in a favorable position to capitalize on the nation’s thriving cannabis industry in order to promote rapid financial growth in the future.
For more information, visit www.growblox.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Growblox Sciences, Inc. (OTCQB: GBLX) is rapidly approaching the impending commencement of cultivation operations through its majority-owned subsidiary, GB Sciences Nevada, LLC. As a result, the company has turned much of its attention in recent weeks toward transitioning from an engineering intensive development stage to the day-to-day operations related to the production and branding of its innovative products. Among these efforts, Growblox has made significant progress in beefing up its staff to meet the increased demands of production efforts while simultaneously promoting sustainable revenue growth.
In July, the company announced the hiring of John Poss as a consultant. Poss brings more than 15 years of consulting experience to the Growblox team, as well as the knowledge gained from operating as a CEO, COO, CFO and CTO of both public and private firms with sales of up to $450 million. In August, the company built upon this relationship by appointing Poss as its new chief financial officer. Following this announcement, Growblox will look to lean on its newest executive’s considerable industry expertise in order to promote a smooth and expeditious strategic transition.
“First joining us as a consultant, the performance of John Poss and his impact on our company, made the hiring of him as a full-time key executive an obvious choice,” Craig Ellins, chief executive officer of Growblox, stated in a news release. “This choice supports our transition from the engineering intensive development stage to the day-to-day operations of producing an excellent product, branding it appropriately, and maximizing our revenue.”
While it continues to increase the size of its staff, Growblox is currently progressing toward the completion of its new cultivation facility, which will provide a pristine and consistent environment for growing and processing medical cannabis that will also safeguard the company’s proprietary technology and equipment. As of its latest update, Growblox plans to complete construction of the facility before the end of 2015, strategically positioning it to initiate revenue-generating operations as early as next year. In preparation, GB Sciences Nevada has already applied for certification to dispense medical cannabis at two locations in Clark County, Nevada, and it is currently awaiting approval.
With the considerable progress of GB Sciences, as well as the company’s ongoing efforts to finalize the production and testing of its groundbreaking GrowBLOX Suites system in 2016, Growblox is in a favorable position to capitalize on the nation’s thriving cannabis industry in order to promote rapid financial growth in the future.
For more information, visit www.growblox.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)GB Sciences, Inc. (GBLX) Stock Research Links
Scroll down for more posts ▼